The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trial

The FLASH (fluid loading in abdominal surgery: saline versus hydroxyethyl starch) trial is an investigator- initiated, national, multicenter, parallel randomized controlled

RRT : Renal Replacement Therapy; AKI: Acute Kidney Injury; RCT : Randomized Controlled Trial; ICU: Intensive Care Unit; AKIKI: Artificial Kidney Initiation in Kidney Injury;

The patients screened for randomization will present septic shock according to the new Sepsis-3 definition and signs of peripheral hypoperfusion (mottling score ≥ 2 and/or finger

Methods: The Cis-A-rein study is an investigator-initiated, prospective, multicenter, double-blind, randomized, controlled study performed to assess the effects of a

short-term efficacy at T4 (treatment response defined as three or more spontaneous, complete bowel movements per week); (2) secondary: efficacy at T5 and T6, symptoms

A pilot study among septic shock patients reported a rather large but non-significant difference between restrictive and usual care without any signals of harm, but the trial

In this large, multinational, randomized trial, critically ill patients with severe acute kidney injury who received an accelerated strategy for the initiation of

Patients eligible for the study must follow the following criteria: age above 18 years old; with chronic or subacute, uni- or bilateral subdural hematomas; confirmed by cere-